CDK4 and melanoma: Melanoma SK‐MEL‐103 cells treated with the CDK4/6 inhibitor, palbociclib, displayed SAβGal staining and increased protein levels of the lysosomal membrane proteins LAMP1 and LAMP2 (Figure 1a).